Product image of Gluformin Er (Metformin Hydrochloride) supplied by GNH India

Gluformin Er

Active Ingredient:
Metformin Hydrochloride
Origin:
EU

Gluformin Er (Metformin Hydrochloride)

Gluformin Er is a prescription medication that contains the active ingredient Metformin Hydrochloride. It is formulated for oral administration and is classified as a biguanide antidiabetic drug. While the specific strength and dosage form are not disclosed, Gluformin Er is marketed in the European Union for the management of type 2 diabetes mellitus, helping to lower elevated blood glucose levels in adult patients as part of a comprehensive treatment plan.

Manufacturer / TM Owner

Pliva Hrvatska D.O.O.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Gluformin Er is indicated for the treatment of type 2 diabetes mellitus and is used as part of a broader glycemic control strategy.

  • Improves fasting plasma glucose levels.
  • Reduces HbA1c when combined with diet and exercise.
  • May be used as monotherapy in patients newly diagnosed with type 2 diabetes.
  • Can be added to other antidiabetic agents such as sulfonylureas or insulin for enhanced control.
  • May be prescribed for patients with overweight or obesity to aid weight management alongside glucose control.

Side Effects

Side effects of Gluformin Er vary in frequency and severity; they are categorized as common or serious.

Common

  • Gastrointestinal upset such as nausea, abdominal discomfort, or diarrhea.
  • Metallic taste in the mouth.
  • Decreased appetite.
  • Mild headache.
  • Skin rash or itching.
  • Fatigue or weakness.

Serious

  • Lactic acidosis, a rare but potentially life‑threatening condition.
  • Severe hypoglycemia, especially when combined with insulin or sulfonylureas.
  • Significant elevation of liver enzymes.
  • Marked increase in serum creatinine indicating renal impairment.

Precautions & Warnings

When prescribing Gluformin Er, clinicians should consider several precautions and warnings to ensure safe use.

  • Assess renal function before initiation and periodically during therapy.
  • Use caution in patients with hepatic impairment or a history of alcohol abuse.
  • Evaluate cardiovascular status, as metformin is contraindicated in acute heart failure.
  • Monitor for signs of vitamin B12 deficiency with long‑term use.
  • Avoid use in patients with known hypersensitivity to metformin or other biguanides.
  • Consider dose adjustment in elderly patients due to altered pharmacokinetics.

Avoid Interactions

Gluformin Er can interact with other medicines; some combinations should be avoided while others require careful monitoring.

Avoid

  • Iodinated contrast agents used for imaging studies.
  • Cimetidine and other strong CYP450 inhibitors.
  • Certain diuretics that may impair renal function.

Use with caution

  • Sulfonylureas or insulin, which may increase risk of hypoglycemia.
  • ACE inhibitors or ARBs, which can affect renal clearance.
  • Oral corticosteroids, which may raise blood glucose levels.

Frequently Asked Questions

Gluformin Er contains metformin, which reduces hepatic glucose production and increases peripheral insulin sensitivity, helping to lower blood glucose levels.

By decreasing the amount of glucose produced by the liver and improving the body's response to insulin, Gluformin Er assists in achieving better glycemic control.

Renal function should be evaluated before starting Gluformin Er, and the drug is generally avoided or dose‑adjusted in patients with moderate to severe renal impairment.

Common adverse effects include gastrointestinal upset (nausea, diarrhea, abdominal discomfort), a metallic taste, decreased appetite, mild headache, skin rash, and fatigue.

Lactic acidosis is rare but serious; patients should seek immediate medical attention if they experience unexplained muscle pain, rapid breathing, abdominal discomfort, or feeling very weak.

Gluformin Er can be combined with insulin, but the combination increases the risk of hypoglycemia, so blood glucose should be closely monitored and insulin doses may need adjustment.

Patients are typically advised to check fasting and post‑prandial glucose levels daily or as directed by their healthcare provider, especially when therapy is initiated or adjusted.

Long‑term use of metformin, the active ingredient in Gluformin Er, may reduce vitamin B12 absorption; periodic monitoring of B12 levels is recommended.

The safety of Gluformin Er in pregnancy and lactation has not been established; clinicians should weigh potential benefits against risks and consider alternative therapies.

Metformin should be temporarily discontinued before and after the administration of iodinated contrast agents, and renal function should be reassessed to avoid the risk of lactic acidosis.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Metformin Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT